Matthew Taylor likened his recently published work alongside doctoral student Gary Dunn to kicking over a rock. Once the ...

Singapore-based marine alternatives biotechnology company UMAMI Bioworks has announced a new cell-cultivated supplement line ...

Synthetic bio company Asimov agreed to collaborate with Cytiva to provide customers with an integrated offering for optimized biologics production. Access includes Asimov’s CHO Edge cell line ...

HLA Protein Technologies, Inc. (formerly Pure Protein, LLC) reports that its new manufacturing expansion is positioned to ...

Find out how single-use optical technology enables accurate, non-invasive cell monitoring in rocking motion bioreactor setups ...

WuXi Biologics, a global CRDMO, has launched TrueSite TI, a targeted integration (TI)-based CHO cell line platform.

In this edition of the biotech bi-weekly, product launches enhancing microbial analysis and biologics development and ...

Although Chinese hamster ovary (CHO) cells have dominated therapeutic protein expression systems for decades, biomanufacturers still must deal with their inconsistent expression levels and varying ...

Researchers explore innovative macrocyclic peptides to target small cell lung cancer, revealing promising therapeutic strategies for this aggressive disease.

Real-time monitoring of cell detachment remains challenging, however, despite being critical for timely bioreactor transfer ...

The FDA approved the combination of lurbinectedin and atezolizumab as first-line maintenance treatment for certain adults ...